Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Andreas Muth"'
Autor:
Sinan Karakaya, Lisa Gunnesson, Erik Elias, Paula Martos-Salvo, Mercedes Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors. PGLs can further be divided into sympathetic (sPGLs) and head-and-neck (HN-PGLs). There are virtually no treatment options, and no cure, for metastatic PCCs a
Externí odkaz:
https://doaj.org/article/bab3867431174edda96dfadd196f72e5
Autor:
Bilal Almobarak, Vishal Amlani, Linda Inge, Tobias Hofving, Andreas Muth, Ola Nilsson, Martin Johansson, Yvonne Arvidsson, Erik Elias
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Small intestinal neuroendocrine tumors (SI-NET) are highly differentiated and genetically stable malignant tumors, yet they often present with advanced metastatic spread at the time of diagnosis. In contrast to many other types of
Externí odkaz:
https://doaj.org/article/d055bd62c17549389cf2301a57fd0067
Autor:
Eva Hessman, Bright I Nwaru, Aldo Rocca, Eleftheria Gkaniatsa, Maria Chiara Brunese, Andreas Muth, Oskar Ragnarsson, Emanuele Bobbio, Daniela Esposito
Publikováno v:
BMJ Open, Vol 13, Iss 7 (2023)
Introduction Treatment strategies for primary aldosteronism (PA) include unilateral adrenalectomy and medical treatment with mineralocorticoid receptor (MR) antagonists. Whether these two different treatment strategies are comparable in mitigating th
Externí odkaz:
https://doaj.org/article/1760216282f9487d9368d0df1dbb8778
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
Autor:
Erik Elias, Arman Ardalan, Markus Lindberg, Susanne E. Reinsbach, Andreas Muth, Ola Nilsson, Yvonne Arvidsson, Erik Larsson
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-8 (2021)
Small intestine neuroendocrine tumors (SI-NETs) are frequently multifocal and metastatic, but their tumourigenesis is still poorly understood. Here, the authors analyse multifocal SI-NET tumours with whole-genome sequencing, revealing the landscape o
Externí odkaz:
https://doaj.org/article/123fb58011ff4c5299d20a2fa8383e2b
Autor:
Oskar Ragnarsson, Andreas Muth, Gudmundur Johannsson, Eleftheria Gkaniatsa, Eva Jakobsson Ung, Sofie Jakobsson
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277902 (2022)
ObjectiveThe burden of symptoms and treatment in patients with primary aldosteronism (PA), as well as the patients' experience of the health care is sparsely studied. The objectives of this study were to describe symptoms considered to be the most tr
Externí odkaz:
https://doaj.org/article/8074a4afda2f4262b404cc507a77e734
Autor:
Tajana Tešan Tomić, Josefin Olausson, Anna Rehammar, Lily Deland, Andreas Muth, Katarina Ejeskär, Staffan Nilsson, Erik Kristiansson, Ola Nilsson Wassén, Frida Abel
Publikováno v:
PLoS Genetics, Vol 16, Iss 6, p e1008803 (2020)
Identification of additional cancer-associated genes and secondary mutations driving the metastatic progression in pheochromocytoma and paraganglioma (PPGL) is important for subtyping, and may provide optimization of therapeutic regimens. We recently
Externí odkaz:
https://doaj.org/article/a6a4615944944cec979301003fb01ffb
Publikováno v:
European Journal of Endocrinology. 188:L1-L2
Autor:
Eleftheria Gkaniatsa, Andreas Muth, Eva Ekerstad, Penelope Trimpou, Manuela Gavric, Gudmundur Johannsson, Daniel S Olsson, Oskar Ragnarsson
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Context Primary aldosteronism (PA) is the most common cause of secondary hypertension. Yet, the incidence of PA in the general population has not been studied. Objective To estimate the incidence of PA in the general population. Design and methods Pa
Autor:
Sinan Karakaya, Lisa Gunnesson, Erik Elias, Paula Martos Salvo, Mercedes Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors. PGLs can further be divided into sympathetic (sPGLs) and head-and-neck (HN-PGLs). There are virtually no treatment options, and no cure, for metastatic PCCs and PGLs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae887625ee735f020682679945f7ac3c
https://doi.org/10.1101/2022.05.27.493680
https://doi.org/10.1101/2022.05.27.493680
Adrenal Venous Sampling in Young Patients with Primary Aldosteronism. Extravagance or Irreplaceable?
Autor:
Magnus Palmér, Oskar Ragnarsson, Eleftheria Gkaniatsa, Augustinas Sakinis, Andreas Muth, Penelope Trimpou
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e2087-e2095
Context Current clinical guidelines suggest that adrenal venous sampling (AVS) may not be mandatory in young patients with primary aldosteronism (PA) and a solitary adrenal adenoma on imaging. Objective The aim of this study was to further elucidate